1. Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016. (2nd May 2019) Authors: Ylescas‐Soria, Jimena; de la Torre‐Lujan, Alfredo H.; Herrera, Luis A.; Miranda, Daniela; Grimaldo, Flavio; Rivas, Silvia; Cervera, Eduardo; Meneses‐García, Abelardo; Leon-Sarmiento, Fidias E.; Prada, Diddier Journal: Cancer medicine Issue: Volume 8:Number 6(2019:Jun.) Page Start: 2942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗